Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › IMVT

SUPERSTRING CAPITAL MANAGEMENT LP position in IMVT

IMMUNOVANT INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 208,368 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$8.0M, representing 5.07% of its reported portfolio and ranking #9 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed IMVT holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)208.37K sh
Reported value held$8.03M
Portfolio Weight5.07%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's IMVT position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in IMVT in Q4 2023 at 203,592 shares (US$8.6M). The position peaked in Q1 2026 at 357,606 shares, worth US$8.9M. Across 6 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 208,368 shares valued at US$8.0M — a reduction of -149,238 shares quarter over quarter.. Notable position changes include a 42% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 203.59K $8.58M New
Q3 2024 12.45K $354.86K New
Q3 2025 341.35K $5.50M New
Q4 2025 288.68K $7.34M Reduce
Q1 2026 357.61K $8.88M Add
Q2 2026 208.37K $8.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 40 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held IMVT?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed IMVT holdings in 6 of the last 11 reported quarters, going back to Q4 2023.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in IMVT?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 208.37K shares of IMVT (IMMUNOVANT INC), valued at $8.03M, representing 5.07% of its reported portfolio and ranking #9.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling IMVT?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in IMVT. The position peaked in Q1 2026 at 357.61K shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.